{
  "_comment": [
    "R-ISS - Revised International Staging System for Multiple Myeloma",
    "多発性骨髄腫の改訂国際病期分類",
    "開発者: IMWG (International Myeloma Working Group) (2015)",
    "原典: Palumbo A, et al. J Clin Oncol. 2015;33(26):2863-9.",
    "参考URL: https://pubmed.ncbi.nlm.nih.gov/26240224/",
    "公式URL: https://www.myeloma.org/international-staging-system-iss-reivised-iss-r-iss",
    "評価: ISSに遺伝子異常とLDHを追加",
    "分類: ステージI (低リスク)、II (中リスク)、III (高リスク)"
  ],
  "title": "R-ISS",
  "description": [
    "多発性骨髄腫の病期分類を行います",
    "血清β2ミクログロブリン、アルブミン、LDH、遺伝子異常を評価します"
  ],
  "fields": [
    {
      "type": "subsection",
      "dispname": "ISS基準項目"
    },
    {
      "type": "text",
      "name": "β2ミクログロブリン",
      "dispname": "血清β2ミクログロブリン",
      "description": "血清β2ミクログロブリン値",
      "required": true,
      "inputmode": "decimal",
      "postfix": "mg/L",
      "testrange": [
        0.5,
        15
      ]
    },
    {
      "type": "text",
      "name": "アルブミン",
      "dispname": "血清アルブミン",
      "description": "血清アルブミン値",
      "required": true,
      "inputmode": "decimal",
      "postfix": "g/dL",
      "testrange": [
        2.0,
        5.0
      ]
    },
    {
      "type": "subsection",
      "dispname": "R-ISS追加項目"
    },
    {
      "type": "radio",
      "name": "LDH",
      "dispname": "血清LDH (乳酸脱水素酵素)",
      "description": "LDHは正常上限を超えているか",
      "required": true,
      "inline": true,
      "selector": [
        "正常範囲内",
        "正常上限を超える"
      ],
      "selectoridx": "0|1"
    },
    {
      "type": "checkbox",
      "name": "高リスク遺伝子異常",
      "dispname": "高リスク遺伝子異常",
      "description": "FISH/細胞遺伝学検査で検出された高リスク異常",
      "selector": [
        "del(17p)",
        "t(4;14)",
        "t(14;16)",
        "該当なし"
      ],
      "selectoridx": "1|1|1|0"
    },
    {
      "type": "subsection"
    },
    {
      "type": "eval",
      "name": "ISSステージ",
      "formula": "((β2ミクログロブリン)) < 3.5 && ((アルブミン)) >= 3.5 ? 'ISS I' : ((β2ミクログロブリン)) >= 5.5 ? 'ISS III' : 'ISS II'",
      "noreport": true
    },
    {
      "type": "eval",
      "name": "高リスク遺伝子異常length",
      "formula": "((高リスク遺伝子異常.index)).length",
      "noreport": true
    },
    {
      "type": "eval",
      "name": "高リスク異常の有無",
      "formula": "( [[高リスク遺伝子異常length]] ) ? 'あり' : 'なし'",
      "noreport": true
    },
    {
      "type": "eval",
      "name": "R_ISSステージ",
      "description": "Revised ISS病期分類",
      "formula": "{{ISSステージ}} == 'ISS I' && {{高リスク異常の有無}} == 'なし' && [[LDH.index]] == 0 ? 'R-ISS I' : ({{ISSステージ}} == 'ISS III' || {{高リスク異常の有無}} == 'あり' || [[LDH.index]] == 1 ? 'R-ISS III' : 'R-ISS II')"
    },
    {
      "type": "eval",
      "name": "予後分類",
      "description": "予後リスク分類",
      "formula": "{{R_ISSステージ}} == 'R-ISS I' ? '低リスク' : {{R_ISSステージ}} == 'R-ISS II' ? '中間リスク' : '高リスク'"
    },
    {
      "type": "eval",
      "name": "5年生存率目安",
      "description": "5年全生存率の目安",
      "formula": "{{R_ISSステージ}} == 'R-ISS I' ? '約82%' : {{R_ISSステージ}} == 'R-ISS II' ? '約62%' : '約40%'"
    },
    {
      "type": "warning",
      "formula": "{{R_ISSステージ}} == 'R-ISS II' || {{R_ISSステージ}} == 'R-ISS III'",
      "name": "Warning: R-ISS II/III"
    },
    {
      "type": "emergency",
      "formula": "{{R_ISSステージ}} == 'R-ISS III'",
      "name": "Emergency: R-ISS III"
    }
  ]
}